SAM
ITCI
Silvercrest Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-118,265
| Closed | -$9.88M | – | 885 |
|
|
2024
Q4 | $9.88M | Sell |
118,265
-583
| -0.5% | -$48.7K | 0.07% | 302 |
|
|
2024
Q3 | $8.7M | Sell |
118,848
-722
| -0.6% | -$52.8K | 0.06% | 284 |
|
|
2024
Q2 | $8.19M | Buy |
119,570
+77,294
| +183% | +$5.29M | 0.06% | 300 |
|
|
2024
Q1 | $2.93M | Sell |
42,276
-13,507
| -24% | -$935K | 0.02% | 460 |
|
|
2023
Q4 | $4M | Sell |
55,783
-22,591
| -29% | -$1.62M | 0.03% | 412 |
|
|
2023
Q3 | $4.08M | Sell |
78,374
-70
| -0.1% | -$3.65K | 0.03% | 394 |
|
|
2023
Q2 | $4.97M | Buy |
78,444
+11,726
| +18% | +$742K | 0.04% | 369 |
|
|
2023
Q1 | $3.61M | Sell |
66,718
-31,756
| -32% | -$1.72M | 0.03% | 403 |
|
|
2022
Q4 | $5.21M | Sell |
98,474
-1,456
| -1% | -$77.1K | 0.04% | 339 |
|
|
2022
Q3 | $4.65M | Sell |
99,930
-2,484
| -2% | -$116K | 0.04% | 341 |
|
|
2022
Q2 | $5.85M | Sell |
102,414
-5,424
| -5% | -$310K | 0.04% | 302 |
|
|
2022
Q1 | $6.6M | Buy |
107,838
+1,279
| +1% | +$78.3K | 0.04% | 327 |
|
|
2021
Q4 | $5.58M | Sell |
106,559
-60,752
| -36% | -$3.18M | 0.04% | 356 |
|
|
2021
Q3 | $6.24M | Sell |
167,311
-2,683
| -2% | -$100K | 0.04% | 352 |
|
|
2021
Q2 | $6.94M | Sell |
169,994
-339
| -0.2% | -$13.8K | 0.05% | 335 |
|
|
2021
Q1 | $5.78M | Sell |
170,333
-21,517
| -11% | -$730K | 0.04% | 356 |
|
|
2020
Q4 | $6.1M | Buy |
+191,850
| New | +$6.1M | 0.04% | 337 |
|